- Home
- CUK vs TEVA Comparison
CUK vs TEVA Comparison
Compare CUK & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUK | TEVA |
|---|---|---|
| Founded | 1972 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.7B | 30.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CUK | TEVA |
|---|---|---|
| Price | $29.17 | $33.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 8 |
| Target Price | $36.05 | ★ $37.25 |
| AVG Volume (30 Days) | 2.4M | ★ 7.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.48% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.05 | N/A |
| Revenue Next Year | $4.08 | $2.97 |
| P/E Ratio | ★ $16.36 | $28.19 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.65 | $12.47 |
| 52 Week High | $33.72 | $37.35 |
Technical Indicators
Market Signals| Indicator | CUK | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 41.72 | 53.33 |
| Support Level | $25.88 | $30.70 |
| Resistance Level | $29.67 | $35.32 |
| Average True Range (ATR) | 1.24 | 0.84 |
| MACD | -0.31 | -0.20 |
| Stochastic Oscillator | 22.85 | 33.82 |
Price Performance
Historical ComparisonAbout CUK Carnival Plc ADS ADS
Carnival is the largest global cruise company, with more than 90 ships in service. Its portfolio of brands includes Carnival Cruise Line, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard in the United Kingdom; Aida in Germany; and Costa Cruises in Southern Europe. It recently folded its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted nearly 14 million guests in 2025.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.